Come up with a name for your new list and we'll add to it:
CellCentric raised a round of funding on April 19, 2005. Investors include
UK Innovation & Science Seed Fund.
CellCentric is a clinical stage biotechnology company focused on the development of the novel drug CCS1477 for prostate (CRPC) and other cancers.…